Xiuting Liu

2.7k total citations · 1 hit paper
46 papers, 1.9k citations indexed

About

Xiuting Liu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Xiuting Liu has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 19 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Xiuting Liu's work include Inflammasome and immune disorders (8 papers), Immune cells in cancer (7 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Xiuting Liu is often cited by papers focused on Inflammasome and immune disorders (8 papers), Immune cells in cancer (7 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Xiuting Liu collaborates with scholars based in China, United States and Hong Kong. Xiuting Liu's co-authors include Rong Hu, Wei Zhou, Qianming Du, Yang Ding, David G. DeNardo, Lei Tao, Ping Lü, Graham D. Hogg, Yajing Wang and Xin Zhang and has published in prestigious journals such as Gastroenterology, Cancer Cell and Cancer Research.

In The Last Decade

Xiuting Liu

45 papers receiving 1.9k citations

Hit Papers

Senescence Defines a Distinct Subset of Myofibroblasts Th... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuting Liu China 22 1.0k 663 488 282 158 46 1.9k
Dae Young Hur South Korea 26 830 0.8× 611 0.9× 453 0.9× 231 0.8× 156 1.0× 102 1.8k
Till Adhikary Germany 20 1.1k 1.1× 536 0.8× 368 0.8× 384 1.4× 145 0.9× 31 1.9k
Qiuping Zhang China 27 940 0.9× 394 0.6× 439 0.9× 435 1.5× 119 0.8× 92 1.8k
Shuli Zhao China 27 1.1k 1.1× 723 1.1× 489 1.0× 484 1.7× 182 1.2× 78 2.1k
Haiyoung Jung South Korea 33 1.4k 1.4× 936 1.4× 534 1.1× 329 1.2× 164 1.0× 87 2.8k
Shaohui Cai China 26 1.3k 1.3× 688 1.0× 969 2.0× 472 1.7× 174 1.1× 65 2.5k
Martin Vaeth Germany 29 989 1.0× 1.1k 1.7× 353 0.7× 176 0.6× 120 0.8× 54 2.5k
Qiang Guo China 21 888 0.9× 686 1.0× 207 0.4× 335 1.2× 87 0.6× 54 1.8k
Lingling Liu China 24 1.1k 1.1× 332 0.5× 202 0.4× 376 1.3× 161 1.0× 105 2.0k
Svetlana Karakhanova Germany 25 943 0.9× 983 1.5× 712 1.5× 313 1.1× 161 1.0× 39 2.5k

Countries citing papers authored by Xiuting Liu

Since Specialization
Citations

This map shows the geographic impact of Xiuting Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuting Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuting Liu more than expected).

Fields of papers citing papers by Xiuting Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuting Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuting Liu. The network helps show where Xiuting Liu may publish in the future.

Co-authorship network of co-authors of Xiuting Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuting Liu. A scholar is included among the top collaborators of Xiuting Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuting Liu. Xiuting Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xuesong, Xiuting Liu, Yanyun Jiang, et al.. (2024). Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasis. Bioactive Materials. 41. 83–95. 8 indexed citations
2.
Belle, Jad I., John Baer, Xiuting Liu, et al.. (2024). Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer. Cancer Discovery. 14(7). 1324–1355. 56 indexed citations breakdown →
3.
Han, Ying, et al.. (2024). 39‐4: An Innovative Decoder‐type GOA for Intelligent Split‐Screen and External Compensation Technology. SID Symposium Digest of Technical Papers. 55(1). 513–516. 1 indexed citations
4.
Zhang, Daoxiang, Varintra E. Lander, Xiuting Liu, et al.. (2022). IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma. Gastroenterology. 162(7). 2047–2062. 33 indexed citations
5.
Lander, Varintra E., Jad I. Belle, Natalie L. Kingston, et al.. (2022). Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade. Cancer Discovery. 12(12). 2774–2799. 66 indexed citations
6.
Liu, Xiuting, Zhenrui Shi, Si‐Yao Lu, et al.. (2022). Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis via Crosstalk With Keratinocytes by Releasing IL-17A. Frontiers in Immunology. 13. 817040–817040. 17 indexed citations
7.
Xiao, Yingping, et al.. (2021). Transcriptome Analysis Reveals the Genes Involved in Growth and Metabolism in Muscovy Ducks. BioMed Research International. 2021(1). 6648435–6648435. 7 indexed citations
8.
Lyu, Wentao, Xiuting Liu, Lizhi Lu, et al.. (2021). Cecal Microbiota Modulates Fat Deposition in Muscovy Ducks. Frontiers in Veterinary Science. 8. 609348–609348. 27 indexed citations
9.
Qiu, Xiaonan, Lin Zheng, Xiuting Liu, et al.. (2021). ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils. Frontiers in Immunology. 12. 714274–714274. 19 indexed citations
10.
Liu, Xiuting, Wentao Lyu, Lei Liu, et al.. (2021). Comparison of Digestive Enzyme Activities and Expression of Small Intestinal Transporter Genes in Jinhua and Landrace Pigs. Frontiers in Physiology. 12. 669238–669238. 10 indexed citations
11.
Liu, Chao, Zhaoying Yao, Jianing Wang, et al.. (2020). Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway. Cell Death and Differentiation. 27(7). 2293–2293. 117 indexed citations
12.
Jiang, Hong, Xiuting Liu, Brett L. Knolhoff, et al.. (2019). Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion. Gut. 69(1). 122–132. 101 indexed citations
13.
14.
Liu, Xiuting, Wei Zhou, Xin Zhang, et al.. (2018). 1‐L‐MT, an IDO inhibitor, prevented colitis‐associated cancer by inducing CDC20 inhibition‐mediated mitotic death of colon cancer cells. International Journal of Cancer. 143(6). 1516–1529. 48 indexed citations
15.
Zhang, Xin, Xiuting Liu, Wei Zhou, et al.. (2018). Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2. Cell Death and Disease. 9(2). 190–190. 34 indexed citations
16.
Qin, Qin, Xiao Xu, Xiuying Wang, et al.. (2018). Glutamate alleviates intestinal injury, maintains mTOR and suppresses TLR4 and NOD signaling pathways in weanling pigs challenged with lipopolysaccharide. Scientific Reports. 8(1). 15124–15124. 34 indexed citations
17.
Zhou, Wei, et al.. (2017). X-11-5-27, a daidzein derivative, inhibits NLRP3 inflammasome activity via promoting autophagy. Experimental Cell Research. 360(2). 320–327. 17 indexed citations
18.
Du, Qianming, Qing Wang, Huimin Fan, et al.. (2016). Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome. Biochemical Pharmacology. 105. 42–54. 84 indexed citations
19.
Lü, Ping, Yajing Wang, Xiuting Liu, et al.. (2016). Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling. Medical Oncology. 33(7). 66–66. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026